PolyPid Ltd.
PYPD
$4.56
$0.225.07%
NASDAQ
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Yield Index
Headlines
5/12/2026
-
TipRanks Financial Blog
5/8/2026
-
MarketBeat
5/6/2026
-
MarketBeat
5/6/2026
-
Globe Newswire
5/2/2026
-
MarketBeat
4/28/2026
-
Globe Newswire
4/26/2026
-
MarketBeat
4/15/2026
-
Zolmax
4/15/2026
-
Zolmax
4/13/2026
-
Globe Newswire
4/13/2026
-
MarketBeat
4/13/2026
-
MarketBeat
4/10/2026
-
MarketBeat
4/2/2026
-
TipRanks Financial Blog
3/31/2026
-
TipRanks Financial Blog
3/31/2026
-
TipRanks Financial Blog
3/31/2026
-
TipRanks Financial Blog
3/31/2026
-
Globe Newswire
3/22/2026
-
Ticker Report
3/19/2026
-
MarketBeat
3/18/2026
-
TipRanks Financial Blog
PolyPid Approaches NDA Submission as New Medicare Model Creates Strong Incentives for SSI Prevention
3/18/2026
-
TipRanks Financial Blog
3/17/2026
-
TipRanks Financial Blog
3/17/2026
-
The Fly
3/17/2026
-
Globe Newswire
Income Statement
Total Revenue (TTM)
--
EBITDA (TTM)
--
EBIT (TTM)
--
Net Income (TTM)
--
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
--
Cash from Investing (TTM)
--
Cash from Financing (TTM)
--
Net Change in Cash (TTM)
--
Filings
Filing Date
Wednesday, February 25, 2026
Period Date
Wednesday, December 31, 2025
Next Filing
Week of May 11 and 15 (est)
Price History
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
--
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
972 7 4719 5700
Address
18 Hasivim Street
Petah Tikva, 4959376
Petah Tikva, 4959376
Country
Year Founded
Business Description
Sector
PolyPid Ltd., a biopharmaceutical company, developing targeted, locally administered, and prolonged-release therapeutics using its proprietary polymer-lipid encapsulation matrix (PLEX) technology...
more